Trial intelligence / Profile preview

ESP Catheters for Pain After Hepatic Resection

NCT04849455Phase 4Recruiting

Sponsor
University of California, San Diego
Start
May 2021
Primary completion
May 2023
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of California, San Diego. Started May 2021; status: recruiting.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04849455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04849455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call